Stomach cancer epidemiology and demographics

Revision as of 13:23, 12 June 2014 by Rim Halaby (talk | contribs)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Stomach cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Stomach Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Endoscopy and Biopsy

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Stomach cancer epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Stomach cancer epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Stomach cancer epidemiology and demographics

CDC on Stomach cancer epidemiology and demographics

Stomach cancer epidemiology and demographics in the news

Blogs on Stomach cancer epidemiology and demographics

Directions to Hospitals Treating Stomach cancer

Risk calculators and risk factors for Stomach cancer epidemiology and demographics

Overview

Epidemiology and Demographics

Stomach cancer represents roughly 2% (25,500) of all new cancer cases yearly in the United States, but it is much more common in Korea, Japan, Great Britain, South America, and Iceland. It is associated with high salt in the diet, smoking, and low intake of fruits and vegetables. Infection with the bacterium H. pylori is the main risk factor in about 80% or more of gastric cancers. It is more common in men.

Gastric or stomach cancer has very high incidence in Korea and Japan. Gastric cancer is the leading cancer type in Korea with 20.8% of malignant neoplasms, the second leading cause of cancer deaths. It is suspected several risk factors are involved including diet, gastritis, intestinal metaplasia and Helicobacter pylori infection. A Korean diet, high in salted, stewed and broiled foods, is thought to be a contributing factor. Ten percent of cases show a genetic component.[1] In Japan and other countries bracken consumption and spores are correlated to stomach cancer incidence.[2] Epidemiologists have yet to fully account for the high rates of gastric cancer as compared to other countries.

A very small percentage of diffuse-type gastric cancers (see Histopathology below) are thought to be genetic. Hereditary Diffuse Gastric Cancer (HDGC) has recently been identified and research is ongoing. However, genetic testing and treatment options are already available for families at risk[3].

Metastasis occurs in 80-90% of individuals with stomach cancer, with a five year survival rate of 75% in those diagnosed in early stages and less than 30% of those diagnosed in late stages. The death rate is 12,400 a year in the United States.

Prevalence

  • In the United States, the age-adjusted prevalence of stomach cancer is 23.5 per 100,000 in 2011.[4]

Incidence

  • The delay-adjusted incidence of stomach cancer in 2011 was estimated to be 7.27 per 100,000 persons in the United States.[4]
  • In 2011, the age-adjusted incidence of stomach cancer was 7.17 per 100,000 persons in the United States.[4]

Age

  • While the overall age-adjusted incidence of stomach cancer in the United States between 2007 and 2011 is 7.5 per 100,000, the age-adjusted incidence of stomach cancer by age category is:[4]
    • Under 65 years: 2.9 per 100,000
    • 65 and over: 38.8 per 100,000

Gender

  • In the United States, the age-adjusted prevalence of stomach cancer by gender in 2011 is:[4]
    • In males: 30.3 per 100,000
    • In females: 18.2 per 100,000
  • In the United States, the delay-adjusted incidence of stomach cancer by gender in 2011 is:[4]
    • In males: 9.95 per 100,000 persons
    • In females: 5.14 per 100,000 persons
  • In the United States, the age-adjusted incidence of stomach cancer by gender on 2011 is:[4]
    • In males: 9.82 per 100,000 persons
    • In females: 5.06 per 100,000 persons
  • Shown below is an image depicting the delay-adjusted incidence and observed incidence of stomach cancer by gender and race in the United States between 1975 and 2011. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.[4]

[Insert figure x.1 from the report]

Race

  • Shown below is a table depicting the age-adjusted prevalence of stomach cancer by race in 2011 in the United States.[4]
All Races White Black Asian/Pacific Islander Hispanic
Age-adjusted prevalence 23.5 per 100,000 18.9 per 100,000 28.8 per 100,000 47.5 per 100,000 33.2 per 100,000
  • Shown below is an image depicting the incidence of stomach cancer by race in the United States between 1975 and 2011.[4]

[Insert figure x.2 from the report]

API: Asian/Pacific Islander; AI/AN: American Indian/ Alaska Native

Percent Distribution of stomach cancer by Histology

Among patients with histologically confirmed cases of stomach cancer, the percent distribution of the types of the disease between YEAR and YEAR in the United States are:[4]


References

  1. AHyuk-Joon Lee, Han-Kwang Yang, Yoon-Ok Ahn, Gastric cancer in Korea Gastric Cancer, Volume 5, Number 3 / September, 2002. DOI:10.1007/s101200200031]
  2. Alonso-Amelot ME, Avendano M., Human Carcinogenesis and Bracken Fern: A Review of the Evidence, Curr Med Chem. 2002 Mar;9(6):675-86
  3. "Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria -- Brooks-Wilson et al. 41 (7): 508 -- Journal of Medical Genetics".
  4. 4.00 4.01 4.02 4.03 4.04 4.05 4.06 4.07 4.08 4.09 4.10 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

Template:WH Template:WS